Prediction of residual/recurrent disease by HPV Genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 51, Issue 2, 2011, Pages 114-118

  Wu, Dongmei ^a   Zheng, Yizhen ^a   Chen, Wei ^b   Guo, Ciren ^b   Yu, Jiang ^a   Chen, Guilin ^b   Huang, Yanling ^b  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Fujian Tumor Hospital   (China)

Author keywords

cervical intraepithelial neoplasia; HPV Genotype; negative margins; residual recurrence

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER SURGERY; COLPOSCOPY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 68; LOOP ELECTROSURGICAL EXCISION PROCEDURE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PAPILLOMAVIRUS INFECTION; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CONIZATION; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79953790672     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2010.01280.x     Document Type: Article

References (25)

1. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-434.
2. Pinto AP, Crum CP,. Natural history of cervical neoplasia: defining progression and its consequence. Clin Obstet Gynecol 2000; 43: 352-362. (Pubitemid 30450551)
3. Lindeque BG,. Management of cervical premalignant lesions. Best Pract Res Clin Obstet Gynaecol 2005; 19: 545-561. (Pubitemid 41263805)
4. Paraskevaidis E, Lolis ED, Koliopoulos G, et al. Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins. Obstet Gynecol 2000; 95: 828-831.
5. Nam K, Chung S, Kim J, et al. Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol 2009; 20 (2): 91-95.
6. Cecchini S, Visioli CB, Zappa M, Ciatto S,. Recurrence after treatment by loop electrosurgical excision procedure (LEEP) of high-grade cervical intraepithelial neoplasia. Tumori 2002; 88 (6): 478-480. (Pubitemid 36193897)
7. Ghaem-Maghami S, Sagi S, Majeed G, Soutter WP,. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol 2007; 8: 985-993. (Pubitemid 47629886)
8. Jakus S, Edmonds P, Dunton C, King SA,. Margin status and excision of cervical intraepithelial neoplasia: a review. Obstet Gynecol Surv 2000; 55: 520-527. (Pubitemid 30624420)
9. Costa S, De Simone P, Venturoli S, et al. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 2003; 90: 358-365. (Pubitemid 36952027)
10. Houfflin Debarge V, Collinet P, Vinatier D, et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecol Oncol 2003; 90: 587-592.
11. Brockmeyer AD, Wright JD, Gao F, Powell MA,. Persistent and recurrent cervical dysplasia after loop electrosurgical excision procedure. Am J Obstet Gynecol 2005; 192: 1379-1381.
12. Boulet GAV, Horvath CAJ, Berghmans S, Bogers J,. Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol Biomarkers Prev 2008; 17 (4): 810-817. (Pubitemid 351536410)
13. Paraskevaidis E, Arbyn M, Sotiriadis A, et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treat Rev 2004; 30: 205-211. (Pubitemid 38418058)
14. Zielinski GD, Bais AG, Helmerhorst TJ, et al. HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv 2004; 59: 543-553. (Pubitemid 38802827)
15. Aerssens A, Claeys P, Beerens E, et al. Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia. Cytopathology 2009; 20 (1): 27-35.
16. Sarian LO, Derchain SF, Andrade LA, et al. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol 2004; 94 (1): 181-186. (Pubitemid 38950517)
17. Alonso I, Torne A, Puig-Tintore LM, et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 2006; 103: 631-636. (Pubitemid 44602179)
18. Bae JH, Kim CJ, Park TC, et al. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int J Gynecol Cancer 2007; 17: 1271-1277. (Pubitemid 350077364)
19. Sarian LO, Derchain SF, Pitta Dda R, et al. Factors associated with HPV persistence after treatment for high-grade cervical intraepithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 2004; 31: 270-274. (Pubitemid 39371059)
20. Song SH, Lee JK, Oh MJ, et al. Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol 2006; 101: 418-422.
21. Park JY, Lee KH, Dong SM, et al. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/ recurrence of cervical intraepithelial neoplasia after conization. Gynecol Oncol 2008; 108: 549-554.
22. Rousseau MC, Abrahamowicz M, Villa LL, et al. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003; 12: 1029-1037. (Pubitemid 37310259)
23. Gargiulo F, Francesco MD, Schreiber C, et al. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res 2007; 125 (2): 176-182. (Pubitemid 46613818)
24. Bachtiary B, Obermair A, Dreier B, et al. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer. Int J Cancer 2002; 102: 237-243. (Pubitemid 35222290)
25. Munagala R, Dona MG, Rai SN, et al. Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response. Int J Oncol 2009; 34 (1): 263-271.